|  | New Team, Old Ways | | By Emma Walsh, Managing Editor, Bill Bonner's Diary Joe Biden is busy lining up his transition team ahead of his move into the Oval Office in January. If nothing else, it promises to be the most diverse team in the White House ever. But having a diverse team doesn’t guarantee a different outcome. When it comes to monetary policies, Biden’s picks aren’t likely to steer the economy away from the cliff-edge on which it now sits. Regards, Emma Walsh
Managing Editor, Bill Bonner’s Diary
 | Life Behind the Mask
Back in the U.S. after nine months on his ranch in Argentina, Bill is adjusting to life in what now feels like a “foreign country.” And he is still trying to figure out if wearing the “holy rag” will ultimately be of any benefit. | |
 | Here Come the Hacks
Continuing his “notes from a foreign country,” Bill muses that over the years, Mother Nature has provided America with the leaders it needed to make a fool of itself. And now, here comes a new team intent on keeping America on the downward slope to its final disaster. | |
 | Status Quo Ante
Today, Bill takes a look at Joe Biden’s new team. But rather than bringing together a panel of experts and new faces from around the country, Biden hasn’t strayed much outside the Beltway. And diversity, not competence, seems to be the order of the day. | |
 | The First Shall Be Last
More from Bill today on Biden’s new team. Lots of “firsts” – first woman, first person of color, etc. And lots of “diversity.” But the appearance of diversity doesn’t guarantee that things at the top will look any different in reality. Biden won’t halt America’s descent into destruction. | |
 | Tesla Is Flying
American stock markets seem to be hitting new all-time highs every week these days. News of an imminent COVID-19 vaccine and a new bailout from the feds is driving stocks higher and higher. Tesla, the electric carmaker, is one such stock whose engine is gunning right now. | |
 | COVID-19 Is Fueling This Tech Trend
The world watches closely as biotechnology companies race to produce a COVID-19 vaccine. But our friend and colleague Jeff Brown is focusing on other biotech firms working on radical new approaches to vaccines and therapies, including one small-cap whose shares, he says, could rocket 1,000% in a single day. | | Like what you’re reading? Send your thoughts to feedback@rogueeconomics.com.
Recommended Links
 | Dire Numbers – Time to Cash Out?
"The largest, fastest change" we've ever seen… Tiger 21, a club of 800 ultra-rich investors, recently started hoarding cash. "We see no easy way out," warns Bank of America. Jeff Bezos – the world's richest man – recently dumped $4.3 billion in stock. What is going on? The alarm bells are ringing. And what you do NOW will determine your future. Jeff Brown – arguably America's most accurate investor – reveals the strange "division" happening in the market right now… Watch This Urgent Briefing Now. |
Get Instant Access Click to read these free reports and automatically sign up for daily research. | Rogue Economics
55 NE 5th Avenue, Delray Beach, FL 33483
www.rogueeconomics.com | | To ensure our emails continue reaching your inbox, please add our email address to your address book.
This editorial email containing advertisements was sent to phanphuongthanh89.822152@blogger.com because you subscribed to this service. To stop receiving these emails, click here.
Rogue Economics welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice.
To contact Customer Service, call toll free Domestic/International: 1-800-681-1765, Mon–Fri, 9am–7pm ET, or email us here.
© 2020 Rogue Economics. All rights reserved. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Rogue Economics. Privacy Policy | Terms of Use | | |
No comments:
Post a Comment